Rank | Gene Set | Z-score |
---|---|---|
1 | exogenous drug catabolic process (GO:0042738) | 9.44627992 |
2 | omega-hydroxylase P450 pathway (GO:0097267) | 9.42991514 |
3 | epoxygenase P450 pathway (GO:0019373) | 9.29073091 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.62003923 |
5 | L-phenylalanine catabolic process (GO:0006559) | 7.62003923 |
6 | L-phenylalanine metabolic process (GO:0006558) | 7.26517470 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.26517470 |
8 | * ethanol oxidation (GO:0006069) | 7.11319387 |
9 | aromatic amino acid family catabolic process (GO:0009074) | 6.96882816 |
10 | indole-containing compound catabolic process (GO:0042436) | 6.42766665 |
11 | indolalkylamine catabolic process (GO:0046218) | 6.42766665 |
12 | tryptophan catabolic process (GO:0006569) | 6.42766665 |
13 | drug metabolic process (GO:0017144) | 6.41562635 |
14 | kynurenine metabolic process (GO:0070189) | 6.27883147 |
15 | oxidative demethylation (GO:0070989) | 6.26094494 |
16 | bile acid biosynthetic process (GO:0006699) | 6.18334078 |
17 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.17702119 |
18 | tryptophan metabolic process (GO:0006568) | 6.02714131 |
19 | glyoxylate metabolic process (GO:0046487) | 5.87279484 |
20 | urea cycle (GO:0000050) | 5.71835687 |
21 | urea metabolic process (GO:0019627) | 5.71835687 |
22 | complement activation, alternative pathway (GO:0006957) | 5.67428063 |
23 | alpha-linolenic acid metabolic process (GO:0036109) | 5.60748413 |
24 | regulation of protein activation cascade (GO:2000257) | 5.60254610 |
25 | * ethanol metabolic process (GO:0006067) | 5.59290198 |
26 | negative regulation of fibrinolysis (GO:0051918) | 5.58180537 |
27 | cysteine metabolic process (GO:0006534) | 5.45154315 |
28 | regulation of fibrinolysis (GO:0051917) | 5.41734314 |
29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.41445047 |
30 | protein carboxylation (GO:0018214) | 5.41445047 |
31 | high-density lipoprotein particle remodeling (GO:0034375) | 5.41299492 |
32 | sulfur amino acid catabolic process (GO:0000098) | 5.38921003 |
33 | regulation of complement activation (GO:0030449) | 5.28065083 |
34 | nitrogen cycle metabolic process (GO:0071941) | 5.25769367 |
35 | bile acid metabolic process (GO:0008206) | 5.21441295 |
36 | S-adenosylmethionine metabolic process (GO:0046500) | 5.20520607 |
37 | serine family amino acid catabolic process (GO:0009071) | 5.13912690 |
38 | phenylpropanoid metabolic process (GO:0009698) | 5.09716343 |
39 | aromatic amino acid family metabolic process (GO:0009072) | 5.05310854 |
40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.02902156 |
41 | regulation of plasminogen activation (GO:0010755) | 4.97768629 |
42 | homocysteine metabolic process (GO:0050667) | 4.88602613 |
43 | tyrosine metabolic process (GO:0006570) | 4.77876300 |
44 | regulation of triglyceride catabolic process (GO:0010896) | 4.77390594 |
45 | reverse cholesterol transport (GO:0043691) | 4.71517393 |
46 | alpha-amino acid catabolic process (GO:1901606) | 4.69276871 |
47 | lysine catabolic process (GO:0006554) | 4.68430948 |
48 | lysine metabolic process (GO:0006553) | 4.68430948 |
49 | negative regulation of protein activation cascade (GO:2000258) | 4.65357495 |
50 | regulation of cholesterol esterification (GO:0010872) | 4.64905922 |
51 | protein-lipid complex remodeling (GO:0034368) | 4.64235134 |
52 | macromolecular complex remodeling (GO:0034367) | 4.64235134 |
53 | plasma lipoprotein particle remodeling (GO:0034369) | 4.64235134 |
54 | acylglycerol homeostasis (GO:0055090) | 4.60760563 |
55 | triglyceride homeostasis (GO:0070328) | 4.60760563 |
56 | amino-acid betaine metabolic process (GO:0006577) | 4.60156290 |
57 | regulation of humoral immune response (GO:0002920) | 4.57872833 |
58 | coenzyme catabolic process (GO:0009109) | 4.57148894 |
59 | bile acid and bile salt transport (GO:0015721) | 4.55801243 |
60 | indolalkylamine metabolic process (GO:0006586) | 4.54502356 |
61 | glycine metabolic process (GO:0006544) | 4.54476421 |
62 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.53909156 |
63 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.53909156 |
64 | negative regulation of blood coagulation (GO:0030195) | 4.52645816 |
65 | negative regulation of hemostasis (GO:1900047) | 4.52645816 |
66 | negative regulation of cholesterol transport (GO:0032375) | 4.50406384 |
67 | negative regulation of sterol transport (GO:0032372) | 4.50406384 |
68 | imidazole-containing compound metabolic process (GO:0052803) | 4.48986776 |
69 | amine catabolic process (GO:0009310) | 4.45621784 |
70 | cellular biogenic amine catabolic process (GO:0042402) | 4.45621784 |
71 | phospholipid efflux (GO:0033700) | 4.43148239 |
72 | cellular glucuronidation (GO:0052695) | 4.41363535 |
73 | cellular ketone body metabolic process (GO:0046950) | 4.40706230 |
74 | alkaloid metabolic process (GO:0009820) | 4.39105321 |
75 | acute-phase response (GO:0006953) | 4.34952099 |
76 | cellular amino acid catabolic process (GO:0009063) | 4.31669175 |
77 | glutamate metabolic process (GO:0006536) | 4.28774315 |
78 | plasma lipoprotein particle clearance (GO:0034381) | 4.27875140 |
79 | serine family amino acid metabolic process (GO:0009069) | 4.26312218 |
80 | benzene-containing compound metabolic process (GO:0042537) | 4.16997253 |
81 | cholesterol efflux (GO:0033344) | 4.14150024 |
82 | negative regulation of coagulation (GO:0050819) | 4.11816854 |
83 | cellular modified amino acid catabolic process (GO:0042219) | 4.09864916 |
84 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.09540621 |
85 | serine family amino acid biosynthetic process (GO:0009070) | 4.08950327 |
86 | negative regulation of wound healing (GO:0061045) | 4.08270634 |
87 | cytolysis (GO:0019835) | 4.07762503 |
88 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.04350237 |
89 | aldehyde catabolic process (GO:0046185) | 4.02824826 |
90 | complement activation, classical pathway (GO:0006958) | 4.00175270 |
91 | fibrinolysis (GO:0042730) | 3.99738985 |
92 | arginine metabolic process (GO:0006525) | 3.99715870 |
93 | low-density lipoprotein particle remodeling (GO:0034374) | 3.96347876 |
94 | positive regulation of hemostasis (GO:1900048) | 3.92518382 |
95 | positive regulation of blood coagulation (GO:0030194) | 3.92518382 |
96 | negative regulation of complement activation (GO:0045916) | 3.92510382 |
97 | complement activation (GO:0006956) | 3.91825574 |
98 | glucuronate metabolic process (GO:0019585) | 3.91432925 |
99 | uronic acid metabolic process (GO:0006063) | 3.91432925 |
100 | plasma lipoprotein particle assembly (GO:0034377) | 3.89828796 |
101 | intestinal cholesterol absorption (GO:0030299) | 3.87910499 |
102 | blood coagulation, intrinsic pathway (GO:0007597) | 3.84268330 |
103 | cofactor catabolic process (GO:0051187) | 3.84173346 |
104 | flavonoid metabolic process (GO:0009812) | 3.83746206 |
105 | protein activation cascade (GO:0072376) | 3.83272640 |
106 | ketone body metabolic process (GO:1902224) | 3.81479596 |
107 | acetyl-CoA metabolic process (GO:0006084) | 3.80157268 |
108 | regulation of bile acid biosynthetic process (GO:0070857) | 3.79815503 |
109 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76677707 |
110 | carboxylic acid catabolic process (GO:0046395) | 3.75486237 |
111 | organic acid catabolic process (GO:0016054) | 3.75486237 |
112 | regulation of cholesterol homeostasis (GO:2000188) | 3.72975750 |
113 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.72579047 |
114 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.72579047 |
115 | cholesterol homeostasis (GO:0042632) | 3.72411514 |
116 | drug catabolic process (GO:0042737) | 3.71440673 |
117 | phospholipid homeostasis (GO:0055091) | 3.70441046 |
118 | sterol homeostasis (GO:0055092) | 3.66215570 |
119 | positive regulation of lipid catabolic process (GO:0050996) | 3.66082227 |
120 | short-chain fatty acid metabolic process (GO:0046459) | 3.65416141 |
121 | sodium-independent organic anion transport (GO:0043252) | 3.60199854 |
122 | NAD biosynthetic process (GO:0009435) | 3.59622916 |
123 | positive regulation of coagulation (GO:0050820) | 3.59208168 |
124 | negative regulation of lipase activity (GO:0060192) | 3.57820617 |
125 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.55867016 |
126 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.55867016 |
127 | plasma lipoprotein particle organization (GO:0071827) | 3.52946323 |
128 | * xenobiotic metabolic process (GO:0006805) | 3.52596461 |
129 | opsonization (GO:0008228) | 3.51477726 |
130 | response to mercury ion (GO:0046689) | 3.35516851 |
131 | heme transport (GO:0015886) | 3.35353622 |
132 | acute inflammatory response (GO:0002526) | 3.29747441 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.38161747 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.21896484 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.19430158 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.51018143 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.28450768 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.04507969 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.68342707 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.08373672 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.98221014 |
10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06385454 |
11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9533014 |
12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96518973 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92437254 |
14 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.74979272 |
15 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.71033767 |
16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.62810789 |
17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61387674 |
18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.47737386 |
19 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44513389 |
20 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40503453 |
21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39061461 |
22 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.38297048 |
23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35797879 |
24 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.33575740 |
25 | VDR_22108803_ChIP-Seq_LS180_Human | 1.30886356 |
26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.28939290 |
27 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.28202608 |
28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.22838562 |
29 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.22336282 |
30 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20059540 |
31 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19408032 |
32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18164408 |
33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17283977 |
34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16941339 |
35 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.14370931 |
36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.10154637 |
37 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.08506199 |
38 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07277616 |
39 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.07112234 |
40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06785491 |
41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04632435 |
42 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.04211655 |
43 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03262048 |
44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.02333918 |
45 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02043926 |
46 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00934004 |
47 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.00891829 |
48 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.00785187 |
49 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99828799 |
50 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.99269011 |
51 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.98682661 |
52 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.98660449 |
53 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.98660449 |
54 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.98553087 |
55 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98005035 |
56 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.96937747 |
57 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.96863134 |
58 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.95815592 |
59 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.95815592 |
60 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94072823 |
61 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93112971 |
62 | NFYA_21822215_ChIP-Seq_K562_Human | 0.92174987 |
63 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91418815 |
64 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.90674409 |
65 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.89297895 |
66 | P300_19829295_ChIP-Seq_ESCs_Human | 0.87968675 |
67 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.87687024 |
68 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.86815981 |
69 | AR_25329375_ChIP-Seq_VCAP_Human | 0.86786886 |
70 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.86170996 |
71 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.86154858 |
72 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.84402480 |
73 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.84264270 |
74 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.83656274 |
75 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.83304028 |
76 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.83304028 |
77 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.82894245 |
78 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82884615 |
79 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.82125855 |
80 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.81602615 |
81 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81549923 |
82 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.81291966 |
83 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.81026824 |
84 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.80896330 |
85 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80583937 |
86 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80461368 |
87 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.79358494 |
88 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.79237077 |
89 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.78948282 |
90 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78353568 |
91 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.78347147 |
92 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77614887 |
93 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.76757492 |
94 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.76654823 |
95 | NFYB_21822215_ChIP-Seq_K562_Human | 0.75822154 |
96 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.75576773 |
97 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.75265916 |
98 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75218435 |
99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74817071 |
100 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74125587 |
101 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74107340 |
102 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74054162 |
103 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71702608 |
104 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68819930 |
105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68506647 |
106 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.67916942 |
107 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67371629 |
108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67371629 |
109 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65467920 |
110 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.65444732 |
111 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61327447 |
112 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.60944727 |
113 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.57644558 |
114 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57201638 |
115 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.56704963 |
116 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.56213223 |
117 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.55884779 |
118 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53975268 |
119 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53679400 |
120 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53124006 |
121 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52502347 |
122 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52424511 |
123 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52355902 |
124 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.52236806 |
125 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51494859 |
126 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50919735 |
127 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.49477345 |
128 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.49154810 |
129 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48996694 |
130 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.47846608 |
131 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.47488863 |
132 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46491940 |
133 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.45184236 |
134 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44467039 |
135 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.44245320 |
136 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.43958765 |
137 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43365074 |
138 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.43278467 |
139 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43250167 |
140 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.41829410 |
141 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41738659 |
142 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41712729 |
143 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.40978103 |
144 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.40535507 |
145 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.40078540 |
146 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.39955261 |
147 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.39450289 |
148 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.39390799 |
149 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39379564 |
150 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.38977410 |
151 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38860844 |
152 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38792161 |
153 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38713506 |
154 | GATA1_19941826_ChIP-Seq_K562_Human | 0.37506205 |
155 | GATA2_19941826_ChIP-Seq_K562_Human | 0.37087035 |
156 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.36862678 |
157 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36704100 |
158 | NCOR_22424771_ChIP-Seq_293T_Human | 0.35310128 |
159 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.34876320 |
160 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.34538053 |
161 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34165850 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.40644805 |
2 | MP0005360_urolithiasis | 7.67637824 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.54593567 |
4 | MP0005365_abnormal_bile_salt | 6.19554080 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.00142415 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.41326510 |
7 | MP0003252_abnormal_bile_duct | 4.00129778 |
8 | MP0010329_abnormal_lipoprotein_level | 3.57416764 |
9 | MP0009840_abnormal_foam_cell | 3.14721506 |
10 | MP0005083_abnormal_biliary_tract | 3.06863935 |
11 | MP0003195_calcinosis | 2.81192339 |
12 | MP0005332_abnormal_amino_acid | 2.71852251 |
13 | MP0001666_abnormal_nutrient_absorption | 2.65623709 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.15790934 |
15 | MP0000609_abnormal_liver_physiology | 2.15411207 |
16 | MP0002118_abnormal_lipid_homeostasis | 2.08884742 |
17 | MP0004019_abnormal_vitamin_homeostasis | 2.07942098 |
18 | MP0003868_abnormal_feces_composition | 1.94819804 |
19 | MP0002138_abnormal_hepatobiliary_system | 1.91473827 |
20 | MP0005319_abnormal_enzyme/_coenzyme | 1.83153288 |
21 | MP0001764_abnormal_homeostasis | 1.66532432 |
22 | MP0009697_abnormal_copulation | 1.63893192 |
23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55514372 |
24 | MP0003011_delayed_dark_adaptation | 1.32160647 |
25 | MP0005451_abnormal_body_composition | 1.31447542 |
26 | MP0003186_abnormal_redox_activity | 1.23508039 |
27 | MP0005647_abnormal_sex_gland | 1.20315489 |
28 | MP0009643_abnormal_urine_homeostasis | 1.19752644 |
29 | MP0003656_abnormal_erythrocyte_physiolo | 1.19540152 |
30 | MP0000598_abnormal_liver_morphology | 1.16434326 |
31 | MP0003705_abnormal_hypodermis_morpholog | 1.15783344 |
32 | MP0009764_decreased_sensitivity_to | 1.05720881 |
33 | MP0000604_amyloidosis | 1.02633478 |
34 | MP0002254_reproductive_system_inflammat | 1.01036140 |
35 | MP0009763_increased_sensitivity_to | 1.00850087 |
36 | MP0002282_abnormal_trachea_morphology | 0.99808331 |
37 | MP0010368_abnormal_lymphatic_system | 0.95086187 |
38 | MP0005636_abnormal_mineral_homeostasis | 0.90014076 |
39 | MP0008469_abnormal_protein_level | 0.88639962 |
40 | MP0009642_abnormal_blood_homeostasis | 0.85489742 |
41 | MP0005408_hypopigmentation | 0.84518011 |
42 | MP0006036_abnormal_mitochondrial_physio | 0.81209833 |
43 | MP0005084_abnormal_gallbladder_morpholo | 0.79349048 |
44 | MP0005187_abnormal_penis_morphology | 0.79075691 |
45 | MP0005376_homeostasis/metabolism_phenot | 0.79046623 |
46 | MP0002876_abnormal_thyroid_physiology | 0.77638286 |
47 | MP0009765_abnormal_xenobiotic_induced | 0.76448465 |
48 | MP0002078_abnormal_glucose_homeostasis | 0.75990774 |
49 | MP0005220_abnormal_exocrine_pancreas | 0.74701264 |
50 | MP0003879_abnormal_hair_cell | 0.72621376 |
51 | MP0002971_abnormal_brown_adipose | 0.70084472 |
52 | MP0004130_abnormal_muscle_cell | 0.69728512 |
53 | MP0005670_abnormal_white_adipose | 0.68842099 |
54 | MP0005334_abnormal_fat_pad | 0.68436214 |
55 | MP0005535_abnormal_body_temperature | 0.68039946 |
56 | MP0005266_abnormal_metabolism | 0.66112069 |
57 | MP0003690_abnormal_glial_cell | 0.65764391 |
58 | MP0001661_extended_life_span | 0.65749073 |
59 | MP0009053_abnormal_anal_canal | 0.63186159 |
60 | MP0005551_abnormal_eye_electrophysiolog | 0.60982296 |
61 | MP0003329_amyloid_beta_deposits | 0.60435267 |
62 | MP0002249_abnormal_larynx_morphology | 0.60158783 |
63 | MP0006035_abnormal_mitochondrial_morpho | 0.58790423 |
64 | MP0000639_abnormal_adrenal_gland | 0.58576666 |
65 | MP0001986_abnormal_taste_sensitivity | 0.56727958 |
66 | MP0005448_abnormal_energy_balance | 0.54361150 |
67 | MP0004381_abnormal_hair_follicle | 0.53761388 |
68 | MP0001756_abnormal_urination | 0.53164007 |
69 | MP0001915_intracranial_hemorrhage | 0.51619251 |
70 | MP0009785_altered_susceptibility_to | 0.50563020 |
71 | MP0002822_catalepsy | 0.50270364 |
72 | MP0006292_abnormal_olfactory_placode | 0.49168601 |
73 | MP0002928_abnormal_bile_duct | 0.49078498 |
74 | MP0005464_abnormal_platelet_physiology | 0.48255575 |
75 | MP0005395_other_phenotype | 0.46407349 |
76 | MP0003718_maternal_effect | 0.45524078 |
77 | MP0005377_hearing/vestibular/ear_phenot | 0.44442964 |
78 | MP0003878_abnormal_ear_physiology | 0.44442964 |
79 | MP0008874_decreased_physiological_sensi | 0.43951913 |
80 | MP0003724_increased_susceptibility_to | 0.43801450 |
81 | MP0003638_abnormal_response/metabolism_ | 0.43550044 |
82 | MP0004142_abnormal_muscle_tone | 0.43396363 |
83 | MP0004782_abnormal_surfactant_physiolog | 0.43329489 |
84 | MP0000579_abnormal_nail_morphology | 0.42548879 |
85 | MP0008873_increased_physiological_sensi | 0.42324319 |
86 | MP0005166_decreased_susceptibility_to | 0.42132358 |
87 | MP0002136_abnormal_kidney_physiology | 0.41674947 |
88 | MP0003436_decreased_susceptibility_to | 0.41594723 |
89 | MP0005248_abnormal_Harderian_gland | 0.40273824 |
90 | MP0009384_cardiac_valve_regurgitation | 0.39621749 |
91 | MP0003953_abnormal_hormone_level | 0.39571079 |
92 | MP0002837_dystrophic_cardiac_calcinosis | 0.39543575 |
93 | MP0005646_abnormal_pituitary_gland | 0.39140928 |
94 | MP0004043_abnormal_pH_regulation | 0.38832497 |
95 | MP0003075_altered_response_to | 0.38704890 |
96 | MP0002796_impaired_skin_barrier | 0.35721186 |
97 | MP0006082_CNS_inflammation | 0.35616037 |
98 | MP0009672_abnormal_birth_weight | 0.35505935 |
99 | MP0009745_abnormal_behavioral_response | 0.34640318 |
100 | MP0008872_abnormal_physiological_respon | 0.32982367 |
101 | MP0005666_abnormal_adipose_tissue | 0.32778774 |
102 | MP0001501_abnormal_sleep_pattern | 0.32700131 |
103 | MP0002332_abnormal_exercise_endurance | 0.31895822 |
104 | MP0009115_abnormal_fat_cell | 0.30855825 |
105 | MP0003633_abnormal_nervous_system | 0.30795261 |
106 | MP0000566_synostosis | 0.30723952 |
107 | MP0000230_abnormal_systemic_arterial | 0.30438014 |
108 | MP0001853_heart_inflammation | 0.29930388 |
109 | MP0000249_abnormal_blood_vessel | 0.29870032 |
110 | MP0002970_abnormal_white_adipose | 0.29083425 |
111 | MP0002909_abnormal_adrenal_gland | 0.28965320 |
112 | MP0002168_other_aberrant_phenotype | 0.28878043 |
113 | MP0001944_abnormal_pancreas_morphology | 0.28285828 |
114 | MP0001243_abnormal_dermal_layer | 0.28240815 |
115 | MP0001440_abnormal_grooming_behavior | 0.28193598 |
116 | MP0001881_abnormal_mammary_gland | 0.27935926 |
117 | MP0000371_diluted_coat_color | 0.27722862 |
118 | MP0001845_abnormal_inflammatory_respons | 0.26459760 |
119 | MP0000427_abnormal_hair_cycle | 0.26054131 |
120 | MP0004883_abnormal_blood_vessel | 0.26000543 |
121 | MP0002132_abnormal_respiratory_system | 0.25141578 |
122 | MP0002060_abnormal_skin_morphology | 0.24277670 |
123 | MP0005164_abnormal_response_to | 0.24164955 |
124 | MP0004264_abnormal_extraembryonic_tissu | 0.23151866 |
125 | MP0005167_abnormal_blood-brain_barrier | 0.22298712 |
126 | MP0000467_abnormal_esophagus_morphology | 0.21963831 |
127 | MP0003631_nervous_system_phenotype | 0.21396318 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 7.60914684 |
2 | Deep venous thrombosis (HP:0002625) | 7.41444312 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.34441999 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.65956301 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 6.62023938 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.43944221 |
7 | Xanthomatosis (HP:0000991) | 6.26613112 |
8 | Complement deficiency (HP:0004431) | 5.87398732 |
9 | Hyperlipoproteinemia (HP:0010980) | 5.42716111 |
10 | Joint hemorrhage (HP:0005261) | 4.78142943 |
11 | Hypolipoproteinemia (HP:0010981) | 4.72811855 |
12 | Epidermoid cyst (HP:0200040) | 4.59006901 |
13 | Hyperammonemia (HP:0001987) | 4.56339565 |
14 | Hyperglycinemia (HP:0002154) | 4.55691506 |
15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.47000596 |
16 | Fat malabsorption (HP:0002630) | 4.33301134 |
17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.31679223 |
18 | Abnormality of complement system (HP:0005339) | 4.28659714 |
19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.23438707 |
20 | Ketosis (HP:0001946) | 4.21308068 |
21 | Abnormality of methionine metabolism (HP:0010901) | 4.17378585 |
22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.08954830 |
23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.05186599 |
24 | Hypoalphalipoproteinemia (HP:0003233) | 4.02359607 |
25 | Abnormality of glycine metabolism (HP:0010895) | 3.94360408 |
26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.94360408 |
27 | Hyperglycinuria (HP:0003108) | 3.92100539 |
28 | Conjugated hyperbilirubinemia (HP:0002908) | 3.89198826 |
29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.81834343 |
30 | Hypoglycemic coma (HP:0001325) | 3.80377099 |
31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.77715799 |
32 | Hypercholesterolemia (HP:0003124) | 3.59972851 |
33 | Fair hair (HP:0002286) | 3.56565626 |
34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36547880 |
35 | Hyperbilirubinemia (HP:0002904) | 3.33053788 |
36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.29319719 |
37 | Steatorrhea (HP:0002570) | 3.29036499 |
38 | Delayed CNS myelination (HP:0002188) | 3.15494387 |
39 | Abnormality of serum amino acid levels (HP:0003112) | 3.09212554 |
40 | Hypochromic microcytic anemia (HP:0004840) | 3.07059976 |
41 | Myocardial infarction (HP:0001658) | 3.03445887 |
42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.03008255 |
43 | Spontaneous abortion (HP:0005268) | 2.99744970 |
44 | Hepatocellular carcinoma (HP:0001402) | 2.98099206 |
45 | Ketoacidosis (HP:0001993) | 2.97407151 |
46 | Neonatal hypoglycemia (HP:0001998) | 2.93227519 |
47 | Systemic lupus erythematosus (HP:0002725) | 2.91286670 |
48 | Skin nodule (HP:0200036) | 2.83717243 |
49 | Metabolic acidosis (HP:0001942) | 2.72051570 |
50 | Osteomalacia (HP:0002749) | 2.71933282 |
51 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.67620323 |
52 | Abnormality of purine metabolism (HP:0004352) | 2.65654483 |
53 | Acanthocytosis (HP:0001927) | 2.63165850 |
54 | Generalized hypopigmentation of hair (HP:0011358) | 2.58267994 |
55 | Lethargy (HP:0001254) | 2.57296409 |
56 | Vascular calcification (HP:0004934) | 2.55198003 |
57 | Dicarboxylic aciduria (HP:0003215) | 2.53752698 |
58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.53752698 |
59 | Abnormal gallbladder morphology (HP:0012437) | 2.50723973 |
60 | Spastic diplegia (HP:0001264) | 2.46786801 |
61 | Hypoglycemic seizures (HP:0002173) | 2.45455778 |
62 | Mitral stenosis (HP:0001718) | 2.44635506 |
63 | Cholelithiasis (HP:0001081) | 2.44046127 |
64 | Pulmonary embolism (HP:0002204) | 2.41188137 |
65 | Glomerulonephritis (HP:0000099) | 2.39827470 |
66 | Gout (HP:0001997) | 2.39650057 |
67 | Neonatal onset (HP:0003623) | 2.38848935 |
68 | Cerebral edema (HP:0002181) | 2.37108639 |
69 | Cholecystitis (HP:0001082) | 2.35702158 |
70 | Abnormal gallbladder physiology (HP:0012438) | 2.35702158 |
71 | Malnutrition (HP:0004395) | 2.32260291 |
72 | Irritability (HP:0000737) | 2.31043388 |
73 | Cardiovascular calcification (HP:0011915) | 2.26073666 |
74 | Sensorimotor neuropathy (HP:0007141) | 2.22372668 |
75 | Purpura (HP:0000979) | 2.21359147 |
76 | Esophageal varix (HP:0002040) | 2.16718992 |
77 | Gingival bleeding (HP:0000225) | 2.15966071 |
78 | Amyloidosis (HP:0011034) | 2.15822120 |
79 | Blue irides (HP:0000635) | 2.15255744 |
80 | Arthropathy (HP:0003040) | 2.14192759 |
81 | Pancreatitis (HP:0001733) | 2.13654525 |
82 | Brushfield spots (HP:0001088) | 2.09757248 |
83 | Menorrhagia (HP:0000132) | 2.09560631 |
84 | Late onset (HP:0003584) | 2.09414071 |
85 | Enlarged kidneys (HP:0000105) | 2.06774251 |
86 | Abnormality of the gallbladder (HP:0005264) | 2.04603610 |
87 | Opisthotonus (HP:0002179) | 2.04217106 |
88 | Thrombophlebitis (HP:0004418) | 2.04198451 |
89 | Abnormality of urine glucose concentration (HP:0011016) | 2.03108129 |
90 | Glycosuria (HP:0003076) | 2.03108129 |
91 | Hemorrhage of the eye (HP:0011885) | 2.03061722 |
92 | Vomiting (HP:0002013) | 2.02561760 |
93 | Poikilocytosis (HP:0004447) | 2.00710839 |
94 | Hyperphosphaturia (HP:0003109) | 2.00159960 |
95 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99342981 |
96 | Generalized aminoaciduria (HP:0002909) | 1.96561325 |
97 | Rickets (HP:0002748) | 1.93333346 |
98 | Abnormal cartilage morphology (HP:0002763) | 1.87142742 |
99 | Abnormality of iron homeostasis (HP:0011031) | 1.86257133 |
100 | Renal cortical cysts (HP:0000803) | 1.86148020 |
101 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.85693222 |
102 | Reduced antithrombin III activity (HP:0001976) | 1.84962837 |
103 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84646818 |
104 | Hypophosphatemic rickets (HP:0004912) | 1.83236570 |
105 | Elevated hepatic transaminases (HP:0002910) | 1.81927606 |
106 | Joint swelling (HP:0001386) | 1.81672391 |
107 | Abnormality of proline metabolism (HP:0010907) | 1.79729604 |
108 | Hydroxyprolinuria (HP:0003080) | 1.79729604 |
109 | Status epilepticus (HP:0002133) | 1.79119542 |
110 | Gangrene (HP:0100758) | 1.78500525 |
111 | Abnormality of vitamin metabolism (HP:0100508) | 1.77841864 |
112 | Hyperglycemia (HP:0003074) | 1.73338267 |
113 | Nephritis (HP:0000123) | 1.71615870 |
114 | Alkalosis (HP:0001948) | 1.70703077 |
115 | Hypothermia (HP:0002045) | 1.69804222 |
116 | Cerebral palsy (HP:0100021) | 1.68130336 |
117 | Abnormal biliary tract physiology (HP:0012439) | 1.67363645 |
118 | Bile duct proliferation (HP:0001408) | 1.67363645 |
119 | Epistaxis (HP:0000421) | 1.66921268 |
120 | Increased serum ferritin (HP:0003281) | 1.58019292 |
121 | Bifid scrotum (HP:0000048) | 1.57770560 |
122 | Abnormal urine phosphate concentration (HP:0012599) | 1.54358155 |
123 | Increased mean platelet volume (HP:0011877) | 1.50949538 |
124 | Elevated alkaline phosphatase (HP:0003155) | 1.49226563 |
125 | Potter facies (HP:0002009) | 1.48583510 |
126 | Facial shape deformation (HP:0011334) | 1.48583510 |
127 | Proximal tubulopathy (HP:0000114) | 1.46591974 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.97161857 |
2 | FGFR4 | 4.69082211 |
3 | SIK1 | 4.56033771 |
4 | ERN1 | 4.45921939 |
5 | TAOK3 | 3.32112390 |
6 | ERBB4 | 3.24477427 |
7 | INSRR | 2.94480548 |
8 | WNK3 | 2.48047822 |
9 | NTRK3 | 2.41222753 |
10 | PIK3CA | 2.36542973 |
11 | MAP2K4 | 2.35679537 |
12 | MAP4K2 | 2.30469560 |
13 | ADRBK2 | 2.18292761 |
14 | MST1R | 2.14714869 |
15 | PKN2 | 2.06486677 |
16 | ACVR1B | 2.05956096 |
17 | PIK3CG | 1.97840197 |
18 | MAPK11 | 1.97528169 |
19 | WNK4 | 1.85590418 |
20 | FLT3 | 1.85134894 |
21 | BMPR1B | 1.84997613 |
22 | TYK2 | 1.71739354 |
23 | LATS1 | 1.70009234 |
24 | TRIB3 | 1.66685825 |
25 | FER | 1.66145310 |
26 | CASK | 1.62895593 |
27 | TNK2 | 1.59209041 |
28 | DAPK2 | 1.48436976 |
29 | PTK6 | 1.48326160 |
30 | ABL2 | 1.46283898 |
31 | FRK | 1.45745083 |
32 | FGFR2 | 1.45595906 |
33 | NEK9 | 1.39152573 |
34 | STK39 | 1.35355779 |
35 | OXSR1 | 1.32668411 |
36 | NLK | 1.31370967 |
37 | MAP3K7 | 1.29947612 |
38 | JAK2 | 1.26294322 |
39 | KDR | 1.23216307 |
40 | CAMKK2 | 1.12263012 |
41 | PINK1 | 1.11524172 |
42 | ERBB2 | 1.10407689 |
43 | PRKAA2 | 1.10405477 |
44 | JAK1 | 1.06281812 |
45 | PDK2 | 1.05935229 |
46 | TBK1 | 1.05512854 |
47 | MAP3K10 | 1.05511641 |
48 | GRK6 | 1.04507970 |
49 | MAP3K14 | 1.02973426 |
50 | NUAK1 | 1.02099728 |
51 | MAPK15 | 1.00036280 |
52 | MAP2K3 | 0.98398715 |
53 | MAPK4 | 0.96512536 |
54 | PRKACA | 0.95612271 |
55 | PRKG1 | 0.95416979 |
56 | PRKCZ | 0.93783990 |
57 | PRKCE | 0.92060501 |
58 | ZAK | 0.90591262 |
59 | MAPK13 | 0.89972242 |
60 | STK38L | 0.89396511 |
61 | BRSK2 | 0.88772771 |
62 | MET | 0.86217610 |
63 | AKT3 | 0.85988690 |
64 | CDK6 | 0.83691823 |
65 | EPHB1 | 0.81213388 |
66 | MAPKAPK3 | 0.77523095 |
67 | TXK | 0.76237169 |
68 | MAPK12 | 0.76215124 |
69 | EPHA3 | 0.76187220 |
70 | IRAK3 | 0.75730307 |
71 | PRKACG | 0.73827097 |
72 | CAMK2G | 0.73711707 |
73 | MAP3K3 | 0.73663876 |
74 | TIE1 | 0.73045614 |
75 | MAP3K4 | 0.72060414 |
76 | CSNK1D | 0.69771121 |
77 | CAMK1D | 0.69586820 |
78 | MAP3K11 | 0.68605819 |
79 | DYRK1B | 0.67272373 |
80 | PRKAA1 | 0.66981009 |
81 | CSK | 0.66787629 |
82 | MAP2K6 | 0.65955715 |
83 | TNIK | 0.65838678 |
84 | ADRBK1 | 0.65665779 |
85 | GSK3A | 0.65412025 |
86 | RIPK1 | 0.61929082 |
87 | SGK3 | 0.61214045 |
88 | FGFR3 | 0.59133882 |
89 | BCR | 0.56916473 |
90 | MAPK7 | 0.56594760 |
91 | CSF1R | 0.56484225 |
92 | PRKACB | 0.56481282 |
93 | PRKCB | 0.55780659 |
94 | CSNK1A1 | 0.54080309 |
95 | PRKCQ | 0.53710989 |
96 | IKBKE | 0.53461638 |
97 | PTK2 | 0.53261513 |
98 | RPS6KA3 | 0.52988718 |
99 | PKN1 | 0.52774783 |
100 | SGK1 | 0.51278564 |
101 | CSNK1E | 0.50678150 |
102 | PDPK1 | 0.50232535 |
103 | KIT | 0.48290892 |
104 | TGFBR2 | 0.47848150 |
105 | CSNK1G1 | 0.46197672 |
106 | EPHA4 | 0.45583915 |
107 | ICK | 0.45455395 |
108 | GRK1 | 0.44933531 |
109 | IGF1R | 0.44466862 |
110 | SGK2 | 0.43892934 |
111 | STK38 | 0.43809275 |
112 | MAP3K13 | 0.43152650 |
113 | MAP3K5 | 0.42055723 |
114 | CDK4 | 0.40494086 |
115 | RET | 0.40386222 |
116 | PRKCG | 0.39949732 |
117 | TAOK2 | 0.38852127 |
118 | MAP2K1 | 0.38464411 |
119 | MKNK2 | 0.37916834 |
120 | DYRK1A | 0.37201270 |
121 | CHUK | 0.36676177 |
122 | EGFR | 0.36276246 |
123 | MTOR | 0.35367079 |
124 | MAP3K6 | 0.33169952 |
125 | CSNK2A1 | 0.32835559 |
126 | CAMK4 | 0.31775324 |
127 | PDK1 | 0.31705866 |
128 | STK11 | 0.31409427 |
129 | PBK | 0.30679281 |
130 | PDK4 | 0.30527324 |
131 | PDK3 | 0.30527324 |
132 | TEC | 0.30045925 |
133 | CAMK2A | 0.29486998 |
134 | PTK2B | 0.28921908 |
135 | IRAK1 | 0.28592385 |
136 | SGK223 | 0.28517304 |
137 | SGK494 | 0.28517304 |
138 | IRAK2 | 0.28133406 |
139 | IKBKB | 0.28018513 |
140 | LATS2 | 0.27813442 |
141 | MUSK | 0.27503432 |
142 | MAP3K1 | 0.27307397 |
143 | SRC | 0.27172011 |
144 | CAMK1G | 0.26816813 |
145 | CSNK1G2 | 0.26697075 |
146 | EIF2AK3 | 0.25608004 |
147 | PRKCA | 0.25492343 |
148 | PAK3 | 0.25122948 |
149 | ABL1 | 0.23513651 |
150 | CSNK1G3 | 0.22713683 |
151 | BMX | 0.21548271 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.71348989 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.58354121 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.36567449 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.32972057 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.05313898 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.83567313 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.74451737 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66058478 |
9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62384113 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.56578337 |
11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.40355166 |
12 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.36299018 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25536691 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17304531 |
15 | Peroxisome_Homo sapiens_hsa04146 | 2.10158527 |
16 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.02843819 |
17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.96642447 |
18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93605254 |
19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93165962 |
20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85707164 |
21 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.83089758 |
22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.80923967 |
23 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.79798599 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78505398 |
25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77992301 |
26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75353156 |
27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73931182 |
28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71709902 |
29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68693869 |
30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.61546440 |
31 | * Retinol metabolism_Homo sapiens_hsa00830 | 1.59777231 |
32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56758377 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55870894 |
34 | Bile secretion_Homo sapiens_hsa04976 | 1.52177038 |
35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48938760 |
36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48081919 |
37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37975733 |
38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35480108 |
39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31610319 |
40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31414718 |
41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30155164 |
42 | * Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28861146 |
43 | ABC transporters_Homo sapiens_hsa02010 | 1.23085300 |
44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23055558 |
45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21537202 |
46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18223783 |
47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17692975 |
48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11519778 |
49 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.11012163 |
50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05589750 |
51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.04295889 |
52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97633256 |
53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96211541 |
54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95557160 |
55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94182701 |
56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87897461 |
57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84895593 |
58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82937588 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.81153996 |
60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78682452 |
61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66636795 |
62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64879130 |
63 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58948232 |
64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55891922 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55582584 |
66 | Prion diseases_Homo sapiens_hsa05020 | 0.49369152 |
67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45512244 |
68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45183777 |
69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44581940 |
70 | Pertussis_Homo sapiens_hsa05133 | 0.27418326 |
71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26269104 |
72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25044107 |
73 | Insulin resistance_Homo sapiens_hsa04931 | 0.23348257 |
74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22368421 |
75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22095494 |
76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21342323 |
77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18504637 |
78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16121807 |
79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.11734664 |
80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10079453 |
81 | Mineral absorption_Homo sapiens_hsa04978 | 0.05802346 |
82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00905925 |
83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2352876 |
84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2308093 |
85 | Bladder cancer_Homo sapiens_hsa05219 | -0.2303640 |
86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2154617 |
87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2142483 |
88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2043466 |
89 | Amoebiasis_Homo sapiens_hsa05146 | -0.2033157 |
90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1935644 |
91 | Phototransduction_Homo sapiens_hsa04744 | -0.1892534 |
92 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1891357 |
93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1866403 |
94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1769058 |
95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1676981 |
96 | Hepatitis C_Homo sapiens_hsa05160 | -0.1673730 |
97 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1669778 |
98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1600797 |
99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1487676 |
100 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1466934 |
101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1371622 |
102 | GABAergic synapse_Homo sapiens_hsa04727 | -0.1364604 |
103 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1277234 |
104 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1185125 |
105 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.1045542 |
106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1044790 |
107 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1040177 |
108 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0934437 |
109 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0816074 |
110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0808967 |
111 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0796694 |
112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0703460 |
113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0550331 |